title: Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy.
authors.forename: Ahmet Emre
authors.initials: AE
authors.lastname: Eskazan
authors.forename: Teoman
authors.initials: T
authors.lastname: Soysal
authors.forename: Seniz
authors.initials: S
authors.lastname: Ongoren
authors.forename: Emine
authors.initials: E
authors.lastname: Gulturk
authors.forename: Burhan
authors.initials: B
authors.lastname: Ferhanoglu
authors.forename: Yildiz
authors.initials: Y
authors.lastname: Aydin
mesh_terms: D000368:Aged; D000069439:Dasatinib; D004232:Diuretics / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D005665:Furosemide / Q000008:administration & dosage; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010490:Pericardial Effusion / Q000139:chemically induced* / Q000188:drug therapy; D010996:Pleural Effusion / Q000139:chemically induced* / Q000188:drug therapy; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D012720:Severity of Illness Index; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects*; D014421:Turkey
chemical_list: D004232:Diuretics; D005938:Glucocorticoids; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D005665:Furosemide; D011505:Protein-Tyrosine Kinases; D000069439:Dasatinib